PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.

Slides:



Advertisements
Similar presentations
Instant Clinical Pharmacology E.J. Begg
Advertisements

First, zero, pseudo-zero order elimination Clearance
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Pharmacotherapy in the Elderly Judy Wong
Pharmacokinetics Questions
Nonlinear pharmacokinetics
One-compartment open model: Intravenous bolus administration
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
Laplace transformation
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Dose Adjustment in Renal and Hepatic Disease
Pharmacokinetics: Asmah Nasser, M.D..
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
Drug Disposition Porofessor Hanan hager Dr.Abdul latif Mahesar College of medicine King Saud University.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
LONGITUDNAL SECTION OF KIDNEY KLECOP, Nipani.
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
CLEARANCE (CL) describes the efficiency of irreversible elimination of a drug from the body by excretion of unchanged drug. Metabolic conversion of the.
Quantitative Pharmacokinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
Objective: Explain the variation in dosing intervals for medications 1)Introduce Half-Life (t 1/2 ) 2)Relate Half-Life to Dosing intervals of aspirin and.
Biotransformation and metabolism
Nonlinear Pharmacokinetics
Pharmacokinetics Introduction
10/13/20151Prof. Mazen Qato. OBJECTIVES 10/13/2015Prof. Mazen Qato2.
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
Pharmacology Department
One Compartment Open Model IV bolus
The General Concepts of Pharmacokinetics and Pharmacodynamics
Multiple dosing: intravenous bolus administration
PHARMACOKINETICS INTRODUCTION
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
Continuous intravenous infusion (one-compartment model)
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
INTRODUCTION CLINICAL PHARMACOKINETICS
BIOPHARMACEUTICS.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Nonlinear Pharmacokinetics
© Paradigm Publishing, Inc.1 Chapter 2 Basic Concepts of Pharmacology.
DEFINITIONS T1/2 & Tmax Cmax AUC 1st order kinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics
Pharmacokinetics 2 General Pharmacology M212
METABOLISME DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA dr. Yunita Sari Pane.
DOSAGE ADJUSTMENT IN RENAL AND HEPATIC DISEASES Course Title : Biopharmaceutics and Pharmacokinetics – II Course Teacher : Zara Sheikh.
Intrinsic Clearance Arthur G. Roberts. Hydrophobic vs. Hydrophilic more bound to plasma proteins more distributed throughout body more metabolized.
INTRODUCTION TO PHARMACOKINETICS M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague, Charles University in Prague,
MULTIPLE DOSAGE REGIMEN
SIVANAGESWARARAO MEKALA ASSISTANT PROFESSOR DEPT OF CLINICAL PHARMACOLOGY.
Allie punke Pharmacokinetics tutoring Fall 2016
Excretion of drugs.
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacokinetics.
Controlled drug release
Pharmacokinetics.
Anticonvulsants: Valproic acid
Lab-3 practical pharmacology
Quantitative Pharmacokinetics
Pharmacokinetics & Drug Dosing
School of Pharmacy, University of Nizwa
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
School of Pharmacy, University of Nizwa
Therapeutic Drug Monitoring chapter 1 part 1
Drug Metabolism.
Presentation transcript:

PLASMA HALF LIFE ( t 1/2 )

 Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical benefit.  Peak Plasma & Trough Concentration : The maximum & minimum drug conc. achieved during repeated dosing cycles.  Target Concentration : The plasma concentration required to produce desired therapeutic effect.

Definition: The time required for the concentration of the drug in the plasma to decrease to one half of its initial value after the peak has been reached.  It is designated as t ½.  A useful parameter derived from Vd & CL.  Important for rational drug therapy because it helps in designing & planning the dosage regimens

 Assimilation kinetics  Elimination kinetics  Plasma half life is a measure of the elimination kinetics  Peak level- beyond which further assimilation cannot take place and elimination processes take over

 It can be calculated by following relationship: t ½ = 0.7 x Vd CL

 

 Decline in Plasma Concentration starting at any steady-state plasma concentration (100 %) of a drug, it will fall as follows:  After 1 t ½ to 50 %  After 2 t ½ to 25 %  After 3 t ½ to 12.5 %  After 4 t ½ to 6.25 %  After 5 t ½ to %

t ½Plasma conc. (mg)

1. Volume of distribution 2. Plasma protein binding 3. Clearance 4. Kinetics Pattern 5. Presence of second drug 6. Diseases 7. Active metabolites 8. Enterohepatic circulation 9. Hepatic blood flow

 Large Vd = long t 1/2

 Albumin  Globulin  Free drug  Bound drug  Class I drugs  Class II drugs

 Increased clearance = decreased t 1/2

 First order kinetics/Exponential kinetics/linear  Uniform or fixed fraction of drug is eliminated in a unit time  t1/2 independent of the drug concentration  constant t ½  Zero order kinetics/Saturation kinetics/non-linear  Michaelis Menten kinetics  Fixed amount of drug is eliminated in a unit of time  Increase dose = t ½ prolonged

First order  Plasma conc. is 100 mg and fraction eliminated is 10 %/hr  So after 1 hr 10 % is eliminated = 10 mg, leaving 90 mg  After 2 nd hr again 10 % is eliminated = 9 mg, leaving 81 mg  After 3 rd hr 10 % of 81 mg is eliminated =8.1 mg, leaving 72.9 mg  After 4 th hr 10 % of 72.9 mg= 7.29 mg, leaving 65.6 mg Changing the dose t 1/2 is not changed

Time (hrs)Plasma conc (mg)

Zero order  100mg dose and amount eliminated is 10mg/hr  So after 1hr 90mg remains  After 2hrs 8omg remains  After 3hrs = 70mg  4hrs =60mg  5hrs = 50mg Increasing dose will increase t 1/2 as enzymes become saturated and elimination capacity decreases

Time (hrs)Plasma conc (mg)

Drugs following zero order kinetics  Aspirin  Phenytoin  Alcohol

 Enzyme inducers ↑ metabolism ( ↓ t ½ )  Enzyme inhibitors ↓ metabolism ( ↑ t ½ )

 Diseases of organ of metabolism/excretion  Hepatic & renal disease  Change in Vd  Change in plasma protein binding

 Biological half life (duration of action) longer than plasma half life ?  Aspirin  Omeprazole

 Aspirin – salicylate  Morphine – morphine 6 glucoronide

 Drugs excreted in bile are reabsorbed from intestine and plasma half life is prolonged  Rifampin  Morphine

 Decreased hepatic blood flow e.g. in cardiogenic shock, cardiac failure, hemorrhage  Prolonged t ½ of drugs with flow dependent CL/extensive hepatic first pass metabolism

 Rate of elimination  Duration of action  Dosing interval  Designing a dosing regimen  Time for steady state concentration  Time for complete elimination

 t ½ indicates rate of elimination  97 % drug eliminated in 5 t ½  Increase t 1/2 – elimination is slow  Decrease t 1/2 – elimination is fast

 t ½ indicates the duration of action of a drug  longer t ½ -long duration of action  shorter t ½ -short duration of action

 t ½ indicates the dosing interval  longer t ½ -long dose interval  shorter t ½ -short dose interval

 t ½ is important for designing a dosage regimen.  It is a plan for drug administration over a period of time.  The interval between doses should not be less than 4 t ½.  Drugs with short half life --- More frequent dosing.  Drugs with long half life --- Less frequent dosing.  Loading dose for drugs with large Vd.

 Time for Steady State (SS)  Rate of elimination equals the Rate of drug administration  Time to reach SS is 4-5 t ½  Time to reach SS is not affected by dose of drug  Time for complete elimination  Important incase of certain adverse effects

 When constant dose of a drug is repeated before 5 t1/2. it would achieve higher peak concentration, because some remnant of the previous dose will be present in the body  This continues with every dose until progressively increasing rate of elimination balances the amount administered over the dose interval  Plasma concentration plateaus and fluctuates about an average steady state level

Plasma Half Life of Some drugs:  Esmolol 09 Min  Aspirin 15 Min  Morphine 1.9 Hours  Propranolol 3.9 Hours  Digoxin 50 Hours  Digitoxin 161 Hours

Thank you!